CDC is requesting OMB approval for one
year to collect information about newborn congenital
cytomegalovirus (CMV) screening. The purpose of this information
collection is to understand the psychosocial impact of newborn
screening on parents whose infants underwent CMV screening as part
of a routine infant CMV screening program in Houston, Texas. The
potential study population includes approximately 70 CMV-infected
children who were symptomatic at birth, 100 CMV-infected children
who were asymptomatic at birth (20 of whom developed sequelae), and
50 controls that were CMV-uninfected. The goals of this information
collection are to: 1) document the positive and negative
psychosocial impacts of newborn CMV screening on parents and their
children; 2) identify modifiable factors that might increase
positive psychosocial impacts and decrease negative psychosocial
impacts of newborn CMV screening; 3) use what is learned about
psychosocial impacts to identify key messages that parents need
relative to newborn CMV screening and follow-up; and 4) to learn
what challenges are associated with obtaining a congenital CMV
diagnosis in the absence of CMV newborn screening.
US Code:
42
USC 241 Name of Law: Research and Investigations Generally
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.